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ABSTRACT 
Timely access to accurate scientific literature in the battle with the 
ongoing COVID-19 pandemic is critical. An unprecedented public 
health risk, this pandemic has motivated research towards 
understanding the disease in general, identifying drugs to treat the 
disease, developing potential vaccines, etc. This has given rise to a 
rapidly growing body of literature that doubles in number of 
publications every 20 days as of May 2020. Providing medical 
professionals with means to quickly analyze the literature and 
discover growing areas of knowledge is necessary for addressing 
their question and information needs. 
In this study we analyze the LitCovid collection, 13,369 COVID-
19 related articles found and curated from PubMed as of May 15 th, 
2020 with the purpose of examining the landscape of literature data 
and presenting it in a format that facilitates information navigation 
and understanding. We do that by applying state-of-the-art named 
entity recognition, classification, clustering and other natural 
language processing (NLP) techniques. Applying named entity 
recognition tools, we capture relevant bioentities (such as diseases, 
internal body organs, etc.) and assess the strength of their 
relationship with COVID-19 by the extent they are discussed in the 
corpus. We also collect a variety of symptoms and co-morbidities 
discussed in reference to COVID-19. Our clustering algorithm 
identifies topics represented by groups of related terms, and 
computes clusters corresponding to documents associated with the 
topic terms. Among the topics we observe several that persist 
through the duration of multiple weeks and have numerous 
associated documents, as well several that appear as emerging 
topics with fewer documents. All the tools and data are publicly 
available, and this framework can be applied to any literature 
collection. Taken together, these analyses produce a 
comprehensive, synthesized view of COVID-19 research to 
facilitate knowledge discovery from literature.  
CCS CONCEPTS 
Natural Language Processing, Artificial Intelligence, Named Entity 
Recognition, Unsupervised Clustering.  
KEYWORDS 
COVID-19, literature-based knowledge discovery, clustering of 
COVID-19 data, named entity recognition, artificial intelligence. 
1 Introduction 
Keeping up to date with COVID-19 related research is increasingly 
challenging as the number of publications on the topic doubles 
every 20 days. Since the beginning of the pandemic, the natural 
language processing community has responded to the needs of 
domain experts by applying state-of-the-art AI and NLP methods 
to improve information understanding, comprehension, and 
discoverability. These efforts include: LitCovid 
(https://www.ncbi.nlm.nih.gov/research/coronavirus/), a daily 
updated website curating and providing access to the most 
comprehensive and informative COVID-19 publications in 
PubMed  (Chen, Allot et al. 2020); CORD-19, a weekly updated 
dataset of articles on COVID-19 and other coronaviruses such as 
MERS and SARS  (https://www.semanticscholar.org/cord19); 
https://www.semanticscholar.org/cord19); Neural Covidex 
(covidex.ai), a neural network based question answering system. 
Due to the rapid growth of the COVID-19 related literature, there 
is an unmet urgency for helping the biomedical and clinical 
community keep afloat in a sea of literature(Brainard 2020). At the 
same time this presents an extraordinary opportunity for research 
in the field of natural language processing to be of critical 
importance. There are already examples of recent studies 
examining this growing body of literature, including 
comprehensive named entity recognition (Wang, Song et al. 2020), 
automatic textual evidence extraction (Wang, Liu et al. 2020), topic 
analysis and visualization (Bras, Gharavi et al. 2020), among 
others. In our approach we combine several directions, including 
NER and topic analysis and visualization, to paint a comprehensive 
picture and juxtapose findings from complementary analyses.  
To this end, we present the entire COVID-19 literature, through 
automated text analytics, in a format that facilitates understanding 
and information navigation to help researchers and medical 
  
 
 
 
professionals grasp the literature landscape of the disease. We 
analyze the collection of PubMed articles made available through 
the LitCovid website; we will refer to these articles as the LitCovid 
collection. To analyze the articles in the LitCovid collection we 
make an extensive use of available NLP tools, including named 
entity recognition (NER) methods, supervised multiclass 
classification strategies, and unsupervised clustering algorithms. 
Using the unsupervised topic analysis and clustering approach 
(Islamaj, Yeganova et al. 2020) we discover meaningful topics in 
the dataset, including both major topics rich in terms and with many 
relevant articles, as well as smaller clusters representing emerging 
topics or trends. 
1 LitCovid collection and characteristics 
Our LitCovid dataset includes 13,369 PubMed articles as of May 
15, 2020. Visualizing the characteristics of the dataset is a useful 
step in exploratory analysis of the literature collection.  
Temporal characteristics. Projecting articles on a timeline allows 
one to observe spikes in the events relevant to the topic of interest. 
For the COVID-19 pandemic we observe an exponential growth 
rate of publications from January 2020 to the present, May 15 th, 
2020 (Figure 1). Literature collections could experience growth 
spikes due to various reasons such as a pandemic, a scientific 
breakthrough, increase/decrease in funding, etc. In the case of 
COVID-19, the expansion is not unexpected due to the severity of 
the outbreak and the determination of scientists worldwide to 
engage the problem.   
 
Semantic classification of articles in LitCovid collection. Since 
the beginning, the articles in the LitCovid collection have been 
categorized into eight broad semantic categories. Specifically, 
topics were assigned by examining article titles, abstracts and, as 
needed, the full article text. The first batch of documents was 
annotated manually. Publications in the LitCovid collection are 
distributed among the topics as follows: Prevention (5,466 articles), 
Treatment (2,802 articles), Diagnosis (1,947 articles), Mechanism 
(1,487 articles), General Information (928 articles), Case Reports 
(832 articles), Transmission (673), and Epidemic Forecasting (227 
articles). 1,843 articles were not identified with any category. 
Furthermore, PubMed articles can be attributed to more than one 
category, resulting in 2,002 articles attributed to two categories, and 
375 articles to three or more categories. The most frequent co-
occuring categories are Mechanism and Treatment (888 pmids), 
Diagnosis and Treatment (641 pmids), and Transmission and 
Prevention(344 pmids), as shown in Figure 2.  
2 Biomedical Entities in LitCovid collection 
We identified most-occurring biomedical concepts in the COVID-
19 literature by extracting the concept annotations in PubTator for 
the LitCovid collection. PubTator is a repository of biomedical 
concept annotations (Wei, Allot et al. 2019), powered by state-of-
the-art entity taggers to identify six concept types: GNormPlus 
(Wei, Kao et al. 2015) for genes, TaggerOne (Leaman and Lu 2016) 
for diseases and cell lines, tmVar (Wei, Phan et al. 2018) for genetic 
variants, SR4GN (Wei, Kao et al. 2012) for species and a 
BlueBERT-based tagger (Peng, Yan et al. 2019) for chemicals. We 
used the PubTator annotations from 5/28/2020 
(https://github.com/ncbi-nlp/PubTator-Covid19). We calculated 
the article mention counts for each entity, that is, the number of 
articles that mention the entity at least once, including synonyms 
(e.g. remdesivir and GS-5734 refer to the same drug). These results 
allow us to observe the entities mentioned and analyze their 
significance over time.  
 
The five drugs most frequently mentioned are hydroxychloroquine, 
chloroquine, remdesivir, tocilizumab, and lopinavir/ritonavir drug 
combination. Chloroquine and hydroxychloroquine combined are 
mentioned extensively, with hydroxychloroquine dominating over 
the course of several weeks, starting from the week of February 29, 
2020. We find many studies targeted at understanding the adverse 
effects of hydroxychloroquine. Remdesivir and the 
lopinavir/ritonavir drug combination are the earliest drugs 
discussed in the corpus.  
 
Figure 1 Number of publications available in PubMed in weekly 
increments from February1 to May 15, 2020. 
 
Figure 2 Distribution of COVID-19 articles by Semantic Categories:  
Prevention, Treatment, Mechanism, Diagnosis, Epidemiologic 
Forecasting, Case Report, General Information. 
  
 
 
The diseases most frequently mentioned are illustrated in Figure 3 
and categorized into 12 high-level groups. Most of the frequently 
mentioned diseases (other than COVID-19 itself) are respiratory 
disorders (e.g. respiratory insufficiency, pneumonia and lung 
injury) that are common effects of COVID-19, or related viral 
infections (e.g. SARS, MERS and arbovirus infections). The 
remainder include diseases that raise the risk of developing severe 
complications – primarily cardiovascular diseases (e.g., 
hypertension), metabolic diseases (e.g., diabetes) – and pathologies 
caused by severe COVID-19 – renal failure, liver damage, and 
complications associated with thrombosis (blood clots) such as 
stroke. Less frequently mentioned are diseases that require special 
management during COVID-19 (especially cancers, though also 
diabetes and cardiovascular diseases), associated conditions used 
to predict severity (such as lymphopenia) and mental health 
conditions caused by the pandemic. Rheumatoid arthritis and lupus 
are mentioned primarily because hydroxychloroquine is an 
established treatment for both.  
Table 1 lists the five most frequently mentioned genes, genetic 
variants and cell lines. Analysis of these entities reflects both the 
current knowledge regarding SARS-CoV-2 infection and current 
areas of investigation. ACE2 (angiotensin-converting enzyme 2) is 
the receptor SARS-CoV-2 uses to enter cells (Zhou, Yang et al. 
2020); it is the human gene most frequently mentioned, and the 
only gene associated with any of the five most frequent human 
genetic variations. Levels of CRP (c-reactive protein), IL-6 
(interleukein-6), and TNF-alpha (tumor necrosis factor alpha) are 
used as markers of SARS-CoV-2 infection severity (Ni, Tian et al. 
 
Figure 3 The most relevant diseases in hierarchy structure. The font size of the disease reflects the frequency.  
 
Table 1 The most frequent genes, cell lines and variants in the LitCovid collection, with their frequencies (in parentheses).  
Top 
Concepts 
Human 
gene 
SARS-CoV-2 
gene 
Human variant Covid19 variant 
CellLine 
Variant 
Corresponding 
Gene 
Variant 
Corresponding 
gene 
1 
ACE2 
(1127) 
Spike 
(236) 
K479N 
(3) 
ACE2 D614G (7) Spike 
Vero E6 
(99) 
2 CRP (680) 
Orf1a/b 
(193) 
S487T 
(3) 
ACE2 V553L (5) Orf1a/b HeLa (40) 
3 
Il-6 
(528) 
Nucleocapsid 
(166) 
rs143936283 
(E329G) (2) 
ACE2 L3606F (5) Orf1a/b MRC5 (37) 
4 ACE (373) 
Envelope 
(76) 
rs2285666 
(8790G>A) (2) 
ACE2 G251V (5) ORF3a 
Hussain SY 
(30) 
5 
TNF-a 
(318) 
Membrane 
(72) 
rs755691167 
(K68E) (2) 
ACE2 
F476L 
(4) 
Orf1a/b Huh7 (29) 
 
 
  
 
 
 
2020). The use of ACE (angiotensin-converting enzyme) 
inhibitors, normally used to treat hypertension, has been 
investigated as potentially increasing the probability  of severe 
disease (Diaz 2020) Four of the most frequently mentioned SARS-
CoV-2 genes refer to structural proteins: spike, nucleocapsid, 
envelope and membrane (Khailany, Safdar et al. 2020) spike is the 
protein used to bind ACE2 to gain entry to the cell (Lan, Ge et al. 
2020) and it is the gene associated with the most frequent SARS-
CoV-2 genetic variant. ORFa/b refers to an open reading frame; it 
is under investigation for clinically significant genetic variants; 
accordingly, it is the SARS-CoV-2 gene associated with the 
majority of frequent SARS-CoV-2 genetic variants. The most 
frequently mentioned cell line is Vero E6, which is frequently used 
as host cells in viral studies, as is HuhH7. HeLa and MRC5 are 
common cell lines. Considering the most frequently mentioned 
entities as a whole, it becomes apparent that the current primary 
focus of genetic research related to COVID-19 is how SARS-CoV-
2 functions – and by extension, what interventions might interrupt 
critical functions – with a secondary focus on clinical markers of 
disease severity and the genetic variants that influence it. 
3 Symptoms and findings in LitCovid collection. 
One of the most frequently asked questions in the media is “What 
are the symptoms of this disease?”. MeSH (Medical Subject 
Headings) is the controlled vocabulary thesaurus at the National 
Library of Medicine used for indexing articles. Article mention 
counts were collected using the Pathological Conditions, Signs and 
Symptoms branch (C23) of MeSH as a dictionary of symptoms. 
Counts for MeSH entry terms (synonyms) were added to the count 
of each MeSH Heading. Mentions are detected in 7,975 of the 
articles in the LitCovid collection. Table 2 illustrates examples of 
symptoms ranging from frequent through moderate and rare. It is 
important to note that some of these symptoms are caused by 
COVID-19. Others are related to underlying conditions that make 
patients more susceptible or increase the chance of a serious case. 
Comparison of the LitCovid collection symptoms with the 
symptom mentions of a similar disease, SARS, allows detection of 
symptoms specific for COVID-19. For the SARS collection we 
chose all 9,085 PubMed articles mentioning SARS through June 
2019. Even though this set includes years of research, it is smaller 
than the LitCovid set. This reflects the volume and intensity of 
COVID-19 research. We computed 95% confidence intervals 
around the frequencies of symptoms appearing in both sets. If the 
intervals did not overlap, the frequency differences are significant. 
Table 3 reports selected symptoms that are unique to each corpus 
as well as some that have significantly different frequencies. 
Further, we examined the common pathological findings in chest 
x-ray and computed tomography (CT) studies reported in the 
LitCovid collection. The findings are based on common thoracic 
disease pathology types, which are expanded from NIH Chest X-
ray 14 labels (Wang et al., 2017). Specifically, we used our 
previous tool, NegBio, to extract these from the figure caption of 
 
Figure 4 The most frequent pathological findings in chest radiograph 
and computed tomography studies 
 
Table 2 Article mentions of selected symptoms in the LitCovid 
collection. Symptoms are from the MeSH C23 tree and can be either a 
result of the disease or a pre-existing condition. We distinguish frequent, 
moderate and rare symptoms.  
Article Mentions Symptom 
559 Fever 
390 Cough 
174 Inflammation 
153 Fatigue 
113 Diarrhea 
<100 Headache, Olfaction Disorders, Infarction,  
Hypoxia, Asymptomatic Infection, Neurologic 
Manifestations 
<10 Fetal Distress, Obesity, Morbid, Taste 
Disorders, Overweight, Hyperventilation, 
Death, Sudden, Weight Loss, Hearing Loss, 
Lethargy 
 
Table 3 Comparison of symptoms in the COVID and SARS literature 
sets. Selected symptoms that either appear in only one set, or appear 
significantly more frequently in one set. Symptoms are from the MeSH 
C23 tree and can result from the disease or a pre-existing condition. 
COVID Only 
 Olfaction Disorders // Myocardial Infarction 
Abdominal Pain // Dizziness  
SARS Only 
 Carcinogenesis // Chromosome Aberrations 
COVID Significantly More Frequent 
 Death // Inflammation // Diarrhea 
Chronic Disease // Recurrence 
SARS Significantly More Frequent 
 Osteonecrosis 
No Significant Difference in Mentions 
 Communicable Diseases // Sneezing // 
Convalescence 
 
  
 
 
chest x-ray and CT images in the full-length PMC OA articles in 
the LitCovid collection (Peng et al., 2017). Figure 4 illustrates the 
passage-level co-mentions of the top ten findings: Ground Glass 
Opacities (GGO), Consolidation, Lung Opacity, Infiltration, 
Pneumonia, Pleural Effusion, Edema, Mass, Nodule, and Fibrosis. 
The most notable mention co-occurrence is between Lung Opacity 
and Consolidation, appearing in 139 articles.  
4 Human organs affected by SARS-CoV-2. 
COVID-19 has been linked to causing multi-system organ failure. 
In this experiment, we wanted to illustrate and summarize the 
research literature as localized by the human organ mentioned. 
Organ mentions are extracted using the en_ner_bionlp13cg_md 
model from SciSpacy (Neumann, King et al. 2019), and entities 
labelled {'ORGAN', 'ANATOMICAL_SYSTEM', 
'IMMATERIAL_ANATOMICAL’, 
'DEVELOPING_ANATOMICAL_STRUCTURE'} mapped to UMLS terms 
using the UMLS normalizer from SciSpacy, with a similarity 
threshold of 0.9. Matching terms were ordered by length, and the 
shortest was used.   Figure 5 is a human organ intensity map 
illustrating the number of article mentions of the top 10 organs.  
5 Clustering the LitCovid literature collection 
Clustering methods can be useful for automatically grouping 
documents into clusters and/or terms into meaningful topics, 
improving human comprehension of a document collections. In this 
work we rely on the Probabilistic Distributional Clustering (PDC) 
algorithm (Islamaj, Yeganova et al. 2020) to generate topics and 
associated document clusters for the LitCovid literature collection. 
Given a document collection, the algorithm computes disjoint term 
sets representing topics in the collection. The algorithm relies on 
the analysis of words and two-word phrases and their frequencies 
and co-occurrences in the free text. It partitions the set of terms 
appearing in the collection of documents into disjoint groups of 
related terms in an unsupervised way. This algorithm is useful in 
that it does not require a user-provided input for the number of 
topics/clusters and does not require any pre-existing knowledge or 
vocabulary for a given body of literature, which is ideal for 
applying to a newly emerged corpus.  
Using this algorithm, we discover meaningful topics that arise from 
the dataset, including both large-size topics defined by many terms 
and retrieving many relevant articles, as well as smaller peaks in 
data representing emerging topics or trends. For each topic, we 
generate titles from the top scoring terms using intuitive rule-based 
techniques. Given a topic we also score all documents in the 
collection by computing a topic-document score based on presence 
of the topic terms in the document. For clarity, we will refer to the 
term sets as topics, and groups of retrieved relevant pmids as 
clusters. 
The PDC-identified clusters on the LitCovid collection provide a 
comprehensive overview of the disease, as reconstructed from the 
literature, as shown in Figure 6. These clusters correspond to 
general and specific topics in dealing with the new disease. We 
observe clusters on treatment options, and case reports, patient 
characteristics and categories. There are clusters of documents 
describing both general topics, as well as specific ones associated 
with different ongoing conditions, such as cardiovascular diseases, 
ongoing cancer treatments etc. We see reports and analysis on 
different drugs, studies on the disease mechanism, testing options 
and other observed challenges and lessons learned. In addition, 
there are clusters of documents on the quality of life and issues of 
mental health in such a situation where life has been disrupted for 
many people. 
5.1 Significant topics in the LitCovid collection. 
The PDC algorithm applied to the LitCovid collection resulted in 
289 clusters with 10 terms or more (we use the threshold of ten 
terms following the choice of parameters in (Islamaj, Yeganova et 
al. 2020)). Topics containing less than 10 terms are usually very 
specific and are considered separately in Section 3.2.  
The significance of a cluster generated by the PDC algorithm is  
naturally correlated with the number of terms in the topic. The most 
term-rich topics produced by the algorithm are: “severe acute 
respiratory syndrome”, “personal protective equipment”, 
“angiotensin converting enzyme”. A large term size generally 
signifies a set of vocabulary terms that are closely related and are 
used together in the literature. Large topics naturally retrieve more 
documents because they contain more terms. However, the results 
also contain many documents returned for topics with a small 
number of terms, describing highly specific aspects of a disease. 
This is expected when we consider the highly specific terms that 
are discussed with the COVID-19 phenomena, which scientists are 
still trying to understand. For example, highly specific term groups 
that retrieve many documents are: “cytokine storm”, 
“lopinavir/ritonavir”, “critically ill patients”, “ethical resource 
allocation”, etc. Here we discuss dominant clusters for the 
 
 
 
 
 
 
 
Figure 5 Human organ intensity heat map illustrating the 
frequency of mentions in the LitCovid collection.  
  
 
 
 
LitCovid collection, both in relation to the term size, as well as in 
relation to the number of documents they retrieve.  
Severe Acute Respiratory Syndrome. The topic contains 290 
unique terms and retrieves 295 pmids. Documents in this cluster are 
focused on the terms:  
{ respiratory // sars // acute respiratory // cov // sars cov // syndrome 
// severe // acute // severe acute // respiratory syndrome}. 
Top scoring articles identified to be relevant to this cluster are very 
much related to each other and to the topic terms: 
• Epidemiology, virology, and clinical features of 
severe acute respiratory syndrome -coronavirus-2 
(SARS-CoV-2; Coronavirus Disease-19).  
• Severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2) and coronavirus disease-2019 (COVID-
19): The epidemic and the challenges. 
• Asymptomatic carrier state, acute respiratory 
disease, and pneumonia due to severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2): 
Facts and myths. 
• The origin, transmission and clinical therapies 
on coronavirus disease 2019 (COVID-19) outbreak - 
an update on the status. 
• The Coronavirus Pandemic: What Does the Evidence 
Show? 
Angiotensin Converting Enzyme. The topic is focused on terms 
related to angiotensin converting enzyme and understanding of the 
disease mechanism. This topic is one of the most dominant topics 
of the corpus and consists of 115 unique terms and 278 relevant 
articles. Ten top scoring terms in the topic and relevant retrieved 
documents are: 
{ angiotensin // converting enzyme // converting // angiotensin // 
converting // ace2 // renin // renin angiotensin // enzyme ace2 // 
blockers } 
• Hypothesis: angiotensin-converting enzyme 
inhibitors and angiotensin receptor blockers may 
increase the risk of severe COVID-19. 
• ACE2, COVID-19, and ACE Inhibitor and ARB Use 
during the Pandemic: The Pediatric Perspective. 
• Renin-Angiotensin System Blockers and the COVID-
19 Pandemic: At Present There Is No Evidence to 
Abandon Renin-Angiotensin System Blockers. 
Pediatric Covid. What about the pediatric patients? What are the 
special considerations, and how should the dosages be adjusted? 
This topic builds on the unique terms listed below, and retrieves 80 
articles: 
{ pediatric // pediatric covid // pediatric cases // overwhelm 
available // sras cov // total infected // preparedness efforts // sras // 
cumulative numbers } 
• Pediatric Airway Management in COVID-19 patients 
- Consensus Guidelines from the Society for 
Pediatric Anesthesia's Pediatric Difficult 
Intubation Collaborative and the Canadian 
Pediatric Anesthesia Society. 
 
Figure 6 Computed clusters are illustrated along the timeline of the 100-day period starting Feb 1, 2020. Each point on the x-axis 
represents a week starting that day. 
Outbreak in 
United States; 
Neonatal 
Management …
Economics of Viral 
Pneumonia;  Critically Ill 
Patients; Epidemiology of …
Bat sl Covzc45;  
Therapeutic use of 
Ritonavir
Diagnostic Imaging of 
Coronavirus Infections; 
Malayan Pangolins; 
Chinese Medical Staff; 
School Closures
Cerebellar Neurobiology; 
Respiratory Rehabilitation 
Guidence
COV Main Protease; RNA-
dependent RNA 
polymerase; vero E6 Cells
Angiotensin Converting 
Enzyme;  Flow Nasal 
Cannula;  Ventilation amid 
Covid
Cutaneous Manifestations; 
Northern Italy; Daily 
Situation Report
Personal Protective 
Equipment;  N95 
Respirators;  Face Masks;  
Loop Mediated Isothermal 
Amplifications
Covid Lockdown Period;  
Hydroxychloroquine HCQ; 
Post-covid Era;  Olfactory 
Dysfunction
Digestive Symptoms;  
Disseminated Intravascular 
Coagulation
Virology of Nasopharynx; 
Resource-Limited 
Circumstances
1-Feb 8-Feb 15-Feb 22-Feb 29-Feb 7-Mar 14-Mar 21-Mar 28-Mar 4-Apr 11-Apr 18-Apr 25-Apr
Clusters in Time Infographic: visualizing the emergence of new topics.
  
 
 
• Brief report: International perspectives on the 
pediatric COVID-19 experience. 
• COVID-19 in Children in the United States: 
Intensive Care Admissions, Estimated Total 
Infected, and Projected Numbers of Severe 
Pediatric Cases in 2020. 
• Pediatric Airway Management in COVID-19 patients 
- Consensus Guidelines from the Society for 
Pediatric Anesthesia's Pediatric Difficult 
Intubation Collaborative and the Canadian 
Pediatric Anesthesia Society. 
• Special considerations for the management of 
COVID-19 pediatric patients in the operating room 
and pediatric intensive care unit in a tertiary 
hospital in Singapore. 
• Chloroquine dosing recommendations for pediatric 
COVID-19 supported by modeling and simulation. 
These examples illustrate the value of the computed topics and 
related document clusters for both the broad view of the literature, 
as well as ability to navigate to and explore a document cluster of 
interest.  
For the illustration in Figure 6, we have selected a subset of 
significant topics containing more than twenty terms and computed 
the onset of the topic from the earliest publication date among the 
most relevant documents. A week when the earliest and most 
relevant retrieved documents date to is considered as a topic onset. 
The topics in Figure 6 are organized by weeks. By studying the 
topics one can reconstruct the focus of published COVID-19 
literature as a function of time. Some examples of early clusters are 
“outbreak in United States” and “air travel”. As the outbreak 
evolves, clusters such as “Diagnostic Imaging of Coronavirus 
Infection” and “Therapeutic use of Ritonavir” start to emerge. In 
late March, topics “Personal Protective Equipment”, “N95 
respirators”, and “Face masks” dominate the space. At the same 
time the community is actively exploring the “Hydroxychloroquine 
HCQ” treatment, and later we have clusters discussing the side 
effects of the treatment with HCQ.  
5.2 Specific topics in the LitCovid collection. 
Specific topics, as discussed above, consist of few terms (less than 
10). However, this does not necessarily mean that they contain a 
small number of documents. As seen in Figure 7, clusters of topics 
“Critically Ill Patients”, or “Lopinavir/Ritonavir”, contain more 
than 50 PMIDs and they are spread throughout the 100 days. This 
shows that such topics remain of significant interest to researchers, 
and they are active research areas. However, most specific topics 
consist of a small set of very closely related documents. In this 
figure we illustrate several such specific clusters grouped into these 
larger categories:  
1) COVID-19 and Other Diseases. In this category we illustrate 
specific cluster of documents discussing issues of patients 
diagnosed with COVID-19, who simultaneously suffer other 
conditions such as: Fulminant Myocarditis, Acute Pulmonary 
 
Figure 7 Small specific topics of LitCovid collection illustrated along the timeline. The figure illustrates small topics defined by few topic terms and the 
temporal spread of the document clusters: COVID-19 and a) other diseases, b) the diagnostic signs and testing procedures, c) different treatment options 
and their studies, and d) safety and prevention. The spread of the cluster reflects the publication dates of the documents co llected in a cluster. The depth 
of color signifies the number of documents.  
  
 
 
 
Embolism, Lung Lesions, Guillain Barre Syndrome, and 
Psoriasis.  
2) COVID-19 Signs and Testing. In this category we have a specific 
topic, with many documents titled “Cytokine Storm”. This 
active research area highlights the fact that this virus causes 
some patients to show a heightened immune response 
compared to others, and the factors that make some people 
more susceptible than others  is still unknown. Other clusters 
in this category are: GGO plus bronchus distortion, 
Gastrointestinal and liver manifestations, and COVID-
induced pneumonia. Some small clusters also reflect research 
on testing mechanisms. 
3) COVID-19 treatment. This category shows an emerging set of 
papers on Crispr-Cas and research on using it for treatment 
purposes, and interesting questions related to the DPP4 
inhibitors and the effect they could have on some patients 
with COVID-19, etc.  
4) Safety and Prevention. Here we find a selection of small clusters 
discussing topics such as: Hand sanitizer, Aerosol Box, how 
to Minimize droplet spread, Biosafety and the impact of 
Travel ban.  
In general, specific topics contain a smaller number of documents 
when compared to the most significant topics. The number of 
documents in these clusters is small because, for a document to be 
assigned to a cluster, it gets weighted with all the topic terms, and 
the combined weight should be above a certain threshold. What we 
see is that these could be highly specific areas of interest to 
physicians and researchers and that they discuss different aspects 
of COVID-19.   
5.3 Associating clusters with the main categories.  
By considering labels of the highest scoring documents retrieved 
for each cluster, we can associate every clusters with the category 
where most of its highest scoring documents fit. We collect all 
labels assigned to the top scoring five documents and associate a 
cluster with the most frequent label in that set. Here we refer the 
reader back to Figure 2, which illustrates some of these clusters and 
their mapping to general categories. For example, “therapeutic use 
of ritonavir” is assigned to treatment, “reported olfactory 
dysfunction” and “glass lesions” are attributed to diagnosis class. 
As documents are frequently labeled with more than one class, so 
are the clusters. Understandably, we observe clusters that 
frequently discuss treatment and mechanism together, and 
prevention and transmission. For example, “angiotensin converting 
enzyme” is attributed to the mechanism class but has a considerable 
number of documents that are assigned to both mechanism and 
treatment. The heatmap in Figure 8 illustrates this phenomenon by 
reflecting the percentage of clusters assigned to a topic with 
significant number of documents that are also assigned to the next 
most relevant class.   
6 Conclusions 
In this study we analyzed the LitCovid collection, 13,369 COVID-
19 related articles (as of May 15, 2020). The purpose of this study 
is to provide a convenient and visual access for researchers and 
others to navigate the landscape of the COVID-19 literature. We 
present a bird eye’s  view of the literature as it spans broad 
categories and more specific topics in time. We identify the most 
frequently mentioned diseases, the most frequently mentioned 
organs, and both the most frequent and the most unusual symptoms, 
which we also compare with the published literature on SARS. In 
addition to the state-of-the-art named entity recognition tools, we 
also applied state of the art clustering methods. We computed 
topics represented by groups of related terms and corresponding 
clusters of documents associated with the topic terms. Among the 
topics we observe several that persist through the duration of 
multiple weeks and have numerous associated documents, while 
others appear as emerging topics with fewer documents. We further 
classify each of these topics into the major categories for easy 
information comprehension. This work is limited by the accuracy 
of the different tools that are used, as well as the human efforts 
required in the analysis. Our goal is to have this analysis available 
on the LitCovid website to benefit Covid-19 researchers 
(https://www.ncbi.nlm.nih.gov/research/coronavirus/). All the 
tools and data are publicly available, and this framework can be 
applied to any literature collection. For the Covid-19 research, 
taken together, these analyses produce a comprehensive, and 
synthesized view to facilitate knowledge discovery from literature.  
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